HIV-1 infection and low steady state viral loads

被引:319
作者
Callaway, DS
Perelson, AS
机构
[1] Los Alamos Natl Lab, Los Alamos, NM 87545 USA
[2] Cornell Univ, Dept Theoret & Appl Mech, Ithaca, NY 14853 USA
关键词
D O I
10.1006/bulm.2001.0266
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Highly active antiretroviral therapy (HAART) reduces the viral burden in human immunodeficiency virus type 1 (HIV-1) infected patients below the threshold of detectability. However, substantial evidence indicates that viral replication persists in these individuals. In this paper we examine the ability of several biologically motivated models of HIV-1 dynamics to explain sustained low viral loads. At or near drug efficacies that result in steady state viral loads below detectability, most models are extremely sensitive to small changes in drug efficacy. We argue that if these models reflect reality many patients should have cleared the virus, contrary to observation. We find that a model in which the infected cell death rate is dependent on the infected cell density does not suffer this shortcoming. The shortcoming is also overcome in two more conventional models that include small populations of cells in which the drug is less effective than in the main population, suggesting that difficulties with drug penetrance and maintenance of effective intracellular drug concentrations in all cells susceptible to HIV infection may underlie ongoing viral replication. (C) 2002 Society for Mathematical Biology.
引用
收藏
页码:29 / 64
页数:36
相关论文
共 56 条
[1]  
ANDERSON R M, 1991
[2]   Human immunodeficiency virus drug therapy and virus load [J].
Bonhoeffer, S ;
Coffin, JM ;
Nowak, MA .
JOURNAL OF VIROLOGY, 1997, 71 (04) :3275-3278
[3]   Virus phenotype switching and disease progression in HIV-1 infection [J].
Callaway, DS ;
Ribeiro, RM ;
Nowak, MA .
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 266 (1437) :2523-2530
[4]  
CALLAWAY DS, 2002, UNPUB INTERMITTENT V
[5]   Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection [J].
Cavert, W ;
Notermans, DW ;
Staskus, K ;
Wietgrefe, SW ;
Zupancic, M ;
Gebhard, K ;
Henry, K ;
Zhang, ZQ ;
Mills, R ;
McDade, H ;
Goudsmit, J ;
Danner, SA ;
Haase, AT .
SCIENCE, 1997, 276 (5314) :960-964
[6]   AIDS - Re-emergence of HIV after stopping therapy [J].
Chun, TW ;
Davey, RT ;
Engel, D ;
Lane, HC ;
Fauci, AS .
NATURE, 1999, 401 (6756) :874-875
[7]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197
[8]   Target cell limited and immune control models of HIV infection: A comparison [J].
De Boer, RJ ;
Perelson, AS .
JOURNAL OF THEORETICAL BIOLOGY, 1998, 190 (03) :201-214
[9]   TOWARDS A GENERAL FUNCTION DESCRIBING T-CELL PROLIFERATION [J].
DEBOER, RJ ;
PERELSON, AS .
JOURNAL OF THEORETICAL BIOLOGY, 1995, 175 (04) :567-576
[10]   Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy [J].
Dornadula, G ;
Zhang, H ;
VanUitert, B ;
Stern, J ;
Livornese, L ;
Ingerman, MJ ;
Witek, J ;
Kedanis, RJ ;
Natkin, J ;
DeSimone, J ;
Pomerantz, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17) :1627-1632